Intelligent Bio Solutions Inc.
INBS
$6.14
-$0.85-12.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.29M | 3.05M | 2.94M | 3.03M | 3.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.29M | 3.05M | 2.94M | 3.03M | 3.19M |
| Cost of Revenue | 1.87M | 1.81M | 1.21M | 1.47M | 1.65M |
| Gross Profit | 1.42M | 1.25M | 1.73M | 1.56M | 1.54M |
| SG&A Expenses | 9.59M | 8.88M | 8.84M | 8.85M | 8.75M |
| Depreciation & Amortization | 1.21M | 1.21M | 1.19M | 1.21M | 1.19M |
| Other Operating Expenses | -884.10K | -816.90K | -510.90K | -421.40K | -441.00K |
| Total Operating Expenses | 13.73M | 13.48M | 13.29M | 13.79M | 13.67M |
| Operating Income | -10.44M | -10.42M | -10.35M | -10.76M | -10.48M |
| Income Before Tax | -10.91M | -10.60M | -10.30M | -10.73M | -10.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.91 | -10.60 | -10.30 | -10.73 | -10.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 38.90K | 36.10K | 34.70K | 36.70K | 36.10K |
| Net Income | -10.87M | -10.57M | -10.26M | -10.70M | -10.42M |
| EBIT | -10.44M | -10.42M | -10.35M | -10.76M | -10.48M |
| EBITDA | -9.45M | -9.45M | -9.40M | -9.77M | -9.51M |
| EPS Basic | -17.27 | -20.83 | -25.57 | -35.48 | -51.26 |
| Normalized Basic EPS | -10.38 | -12.79 | -15.95 | -22.13 | -31.97 |
| EPS Diluted | -17.27 | -20.83 | -25.59 | -35.50 | -51.28 |
| Normalized Diluted EPS | -10.38 | -12.79 | -15.95 | -22.13 | -31.97 |
| Average Basic Shares Outstanding | 2.59M | 2.11M | 1.72M | 1.35M | 988.20K |
| Average Diluted Shares Outstanding | 2.59M | 2.11M | 1.72M | 1.35M | 988.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |